Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Chang

Showing results (111-120 of 137) with videos related to

Pageof 14
Sort By:
Hepatology (Baltimore, Md.)|January 6, 2015
Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantationXavier Forns, Michael Charlton, Jill Denning, et al.
European Heart Journal|October 2, 2015
The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillationEmily C O'Brien, DaJuanicia N Simon, Laine E Thomas, et al.
Clinical Cardiology|January 1, 2016
Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT-AF RegistryLarry R Jackson, Sung Hee Kim, Jonathan P Piccini, et al.
The American Journal of Cardiology|March 9, 2019
Blood Pressure Control and Cardiovascular Outcomes in Patients With Atrial Fibrillation (From the ORBIT-AF Registry)Sreekanth Vemulapalli, Taku Inohara, Sunghee Kim, et al.
Circulation|July 18, 2013
Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) RegistryBenjamin A Steinberg, Sunghee Kim, Jonathan P Piccini, et al.
Journal of the American College of Cardiology|June 27, 2015
Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation CohortLarry A Allen, Gregg C Fonarow, DaJuanicia N Simon, et al.
American Heart Journal|July 29, 2014
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II: rationale and design of the ORBIT-AF II registryBenjamin A Steinberg, Rosalia G Blanco, Donna Ollis, et al.
The American Journal of Medicine|January 23, 2016
Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery DiseaseRenato D Lopes, Meena Rao, DaJuanicia N Simon, et al.
American Heart Journal|June 22, 2015
Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registrySean D Pokorney, DaJuanicia N Simon, Laine Thomas, et al.
Circulation. Cardiovascular Quality and Outcomes|June 14, 2013
Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryMichael W Cullen, Sunghee Kim, Jonathan P Piccini, et al.
Pageof 14

Showing results (111-120 of 137) with videos related to

Sort By:
Pageof 14
Hepatology (Baltimore, Md.)|January 6, 2015
Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantationXavier Forns, Michael Charlton, Jill Denning, et al.
European Heart Journal|October 2, 2015
The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillationEmily C O'Brien, DaJuanicia N Simon, Laine E Thomas, et al.
Clinical Cardiology|January 1, 2016
Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT-AF RegistryLarry R Jackson, Sung Hee Kim, Jonathan P Piccini, et al.
The American Journal of Cardiology|March 9, 2019
Blood Pressure Control and Cardiovascular Outcomes in Patients With Atrial Fibrillation (From the ORBIT-AF Registry)Sreekanth Vemulapalli, Taku Inohara, Sunghee Kim, et al.
Circulation|July 18, 2013
Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) RegistryBenjamin A Steinberg, Sunghee Kim, Jonathan P Piccini, et al.
Journal of the American College of Cardiology|June 27, 2015
Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation CohortLarry A Allen, Gregg C Fonarow, DaJuanicia N Simon, et al.
American Heart Journal|July 29, 2014
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II: rationale and design of the ORBIT-AF II registryBenjamin A Steinberg, Rosalia G Blanco, Donna Ollis, et al.
The American Journal of Medicine|January 23, 2016
Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery DiseaseRenato D Lopes, Meena Rao, DaJuanicia N Simon, et al.
American Heart Journal|June 22, 2015
Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registrySean D Pokorney, DaJuanicia N Simon, Laine Thomas, et al.
Circulation. Cardiovascular Quality and Outcomes|June 14, 2013
Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryMichael W Cullen, Sunghee Kim, Jonathan P Piccini, et al.
Pageof 14